PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding PolyPid Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 27 | 27 | 0 |
| Shares | 1.52M | 1.13M | −389.5K (−25.7%) |
| Value | $8.71M | $6.10M | −$2.61M (−30.0%) |
New holders (4)
Institutions that held PolyPid Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JFG Wealth Management, LLC | 39,063 | $213.0K | 0.06% |
| Renaissance Technologies LLC | 13,214 | $72.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,009 | $6.00K | 0.00% |
| Royal Bank of Canada | 357 | $2.00K | 0.00% |
Sold out (4)
Institutions that held PolyPid Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Moore Capital Management, LP | 125,203 | $719.0K |
| Barclays PLC | 71,000 | $408.0K |
| Federated Hermes, Inc. | 20,000 | $115.0K |
| Virtu Financial LLC | 13,611 | $78.0K |